Actively Recruiting
First Study of a Degradable Shoulder Spacer to Treat Symptomatic Massive Rotator Cuff Tears in Patients Aged 50 and Older
Led by Voll Medical Technologies Ltd. · Updated on 2026-07-30
20
Participants Needed
4
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the initial safety, effectiveness, and clinical outcomes of a degradable shoulder spacer in patients over 50 years old with symptomatic massive rotator cuff tears MRCT. This first-in-human study is designed to better understand how this device may work as a treatment option for this condition. Participants will receive the Voll Degradable Shoulder Spacer device as part of the study. The study follows a single-group design, where all participants are treated with this device and monitored for outcomes. The study focuses on safety and effectiveness, tracking device-related serious adverse events for up to 12 months after implantation. During the study, participants will undergo post-operative evaluations and visits to monitor their recovery and the devices performance. Researchers will collect data on adverse events and clinical outcomes over the course of one year. Participants are expected to be generally healthy, independent adults who can attend all follow-up visits and evaluations during the study period.
CONDITIONS
Brief Title
Voll Degradable Shoulder Spacer FIH Study
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here